IQVIA’s Market Feedback Report (MFR) and PharmaTrac’s Acquaint report both analyze the Indian Pharmaceutical Market (IPM) for November 2025, revealing consistent growth trends driven by chronic therapies despite minor data discrepancies. MFR reports MAT sales at ₹246,846 Cr with 8.2% growth, while PharmaTrac shows ₹238,968 Cr at 8.8% YoY and 8.8% 5-year CAGR. Critical analysis…
Free Membership Required
You must be a Free member to access this content.
Already a member? Log in here
